Phase 1, Open-Label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer during Surgical Procedures

Grant

Awarded By

Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • Contributor

  • garima   Investigator  
  • kwithrow   Investigator  
  • lisle   Investigator  
  • mojack   Investigator  
  • morlandt   Investigator  
  • wcarroll   Principal Investigator  
  • Benjamin Greene   Investigator